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Abstract: Magnetic microspheres measuring 15–35 µm in diameter are believed to be useful 
for intra-arterial hyperthermia. In the present study, we attempted to prepare titanium dioxide 
(TiO2) microspheres containing magnetic nanoparticles (MNPs). MNP-containing TiO2 
microspheres with diameters of approximately 30 µm were successfully obtained by sol-gel 
reaction of titanium tetraisopropoxide in a water-in-oil emulsion with added cosurfactant of 
1-butanol and subsequent heat treatment at 200°C. The microspheres showed ferrimagnetism
owing to high content of MNPs in approximately 60 wt% and had a low-crystalline TiO2 
matrix. Furthermore, the agar phantom was heated to above 43°C after approximately 1 min 
under an alternating magnetic field of 100 kHz and 300 Oe and showed in vitro 
biocompatibility similar to that of MNP-free TiO2 microspheres. 
Keywords: magnetic nanoparticles; TiO2; microspheres; hyperthermia 
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INTRODUCTION 
Hyperthermia is a minimally invasive treatment for malignant tumors that has minor side 
effects. In clinical practice, the tumor is heated externally by utilizing hot water, microwave 
heating, ultrasonic heating, or other methods. However, these conventional heating methods 
are not effective for tumors that occur in deeper regions of the body. Recently, local 
hyperthermia treatment using magnetic materials has received considerable attention, because 
magnetic materials can generate heat by relaxation loss or hysteresis loss under an alternating 
magnetic field of 100–300 kHz.1,2 Moreover, clinical trials examining the efficacy of 
thermotherapy using magnetic nanoparticles have been attempted in the United States of 
America (USA) and in countries in the European Union (EU).3-5 
Local hyperthermia using magnetic nanoparticles, as described above, may be a 
promising next-generation tumor treatment. Similarly, research in our laboratory has focused 
on intra-arterial hyperthermia using magnetic microspheres measuring 15–35 µm in 
diameter.6-10 To date, ferrimagnetic magnetite microspheres,6 magnetic nanoparticle 
(MNP)-containing silica (SiO2) microspheres,
7 iron-containing SiO2 microspheres
8, and 
MNP-containing titanium dioxide (TiO2) microspheres
9,10 have been prepared, and their 
structures, magnetic properties, and in vitro heat-generating ability have been investigated. 
However, MNP-containing TiO2 microspheres have a mean diameter smaller than 10 µm, 
which is too small for intra-arterial therapy. 
Page 3 of 28 Journal of Biomedical Materials Research: Part B - Applied Biomaterials
4 
In our previous study, we used the sol-gel reaction of titanium alkoxide in water-in-oil 
(W/O) emulsion during preparation of the MNP-TiO2 microspheres. It is difficult to increase 
the sizes of the microspheres only by modification of reaction conditions because hydrolysis 
and polycondensation reactions of titanium alkoxide can occur easily. On the other hand, in a 
micro-emulsion reaction system, addition of cosurfactant, such as a short-chain alcohol, can 
affect the shapes and sizes of the micro-emulsion droplets,11,12 and similar effects can be 
expected in our W/O emulsion reaction system. 
Accordingly, in this study, we aimed to obtain larger microspheres by adding 1-butanol as 
a cosurfactant to the reaction system. We then investigated the structures, magnetic properties, 
in vitro heat-generating ability, and in vitro biocompatibility of the resulting microspheres. 
MATERIALS AND METHODS 
Sol-gel synthesis of samples 
The oil phase consisted of 40 g of kerosene, 3 g of sorbitan monooleate (span 80), 1 g of 
sorbitan monostearate (span 60), and 3 mL of 1-butanol. The oil phase was then placed in a 
water bath and heated to 30°C for 20 min while being stirred with a homogenizer at 
approximately 1,500 rpm. Here, in order to obtain homogeneity of the oil phase, the 
surfactants of span 60 and span 80 were first added to kerosene, and 1-butanol was then added 
to the mixture of surfactants and kerosene. Commercially available MNPs (product no. 
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637106; Sigma-Aldrich Corp., USA) of 3 g were then introduced into the oil phase along with 
4.2 mL of ultrapure water while being vigorously stirred. 
The water phase, which consisted of 2.7 g methanol, 4.5 g titanium tetraisopropoxide 
(TTIP), and 3.2 g diethanolamine, was added to the stirred solution. In this study, we prepared 
samples with different total reaction times of 30 min (10 min at 30°C, 10 min at 40°C, and 10 
min at 55°C) or 60 min (20 min at 30°C, 20 min at 40°C, and 20 min at 55°C). Samples 
prepared with total reaction times of 30 and 60 min were denoted as samples RT-30 and 
RT-60, respectively. The gel particles were separated by centrifugation at 1,735 × g for 5 min 
and washed with ethanol four times. The gel particles were then dried at 36.5°C for 12 h and 
150°C for 3 h. In order to prevent oxidization of MNPs, heat treatment was applied at 200°C 
for 3 h. As a reference sample for in vitro biocompatibility tests, MNP-free TiO2 microspheres 
were also prepared. Unless indicated, all reagents used were obtained from Wako Pure 
Chemical Industries (Japan). 
Characterization of samples 
The crystalline phase of the samples was verified by powder X-ray diffraction (XRD; 
Miniflex 600HDA; Rigaku, Japan) using the following settings: X-ray source, CuKα; X-ray 
power, 40 kV, 15 mA; scanning rate, 2θ = 10°/min. Particle sizes and crystal morphologies of 
the samples were observed with a scanning electron microscope (SEM; VE-8800; Keyence, 
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Measurement of the magnetic properties of samples 
The saturation magnetization (Ms) and coercive force (Hc) of the samples were measured 
with a vibrating sample magnetometer (VSM; VSM-5; Toei, Japan) in magnetic fields up to 
10 kOe at room temperature at a frequency of 80 Hz. We assumed that the area of the 
hysteresis loop measured under the applied magnetic field (100 kHz, 300 Oe) was the same as 
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that measured in a field of 300 Oe using the VSM. The heat generated by the samples was 
calculated using the following equation:13 
 =    × 10
where f is frequency (in Hz), H is the magnetic field strength (in Oe), and B is the 
magnetization (in emu) of a sample in an applied magnetic field. The term ∮  is the area
of the hysteresis loop in the applied magnetic field. Therefore, in our calculations, f = 100 kHz 
and the area of the hysteresis loop measured at 300 Oe using the VSM was substituted for 
∮ .
Measurement of the in vitro heat-generating ability of samples 
A mass of 0.2 g of a sample was dispersed into a 3-mL hot agar solution (agar content = 1.0 
wt%) in a glass tube, and the agar was then solidified in cold water. The concentration of the 
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sample in the agar phantom was 67 mg/mL. The glass tubes containing the samples were 
placed in an applied alternating current magnetic field of 100 kHz and 300 Oe, in accordance 
with our previous studies.14 The heat generated by the samples was investigated by measuring 
changes in the temperature of the agar phantom as a function of time using a ﬁber optic 
temperature sensor (TempSens; Opsens Inc., Canada). 
Evaluation of the in vitro biocompatibility of samples 
Similar to our previous study,9 the in vitro biocompatibility of samples was evaluated using 
fibroblasts. Rat-derived Rat-1 fibroblasts were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM; Wako Pure Chemical Industries, Japan) containing 10% horse serum 
(Thermo Fisher Scientific, Waltham, MA, USA), 100 U/mL penicillin (Meiji Seika Kaisha, 
Ltd., Japan), and 100 µg/mL streptomycin (Meiji Seika Kaisha, Ltd., Japan). The cells were 
routinely subcultured every third day in a 60.1-cm2 culture dish at 37°C in humidified air with 
5% CO2. 
Cell experiments were conducted by establishing the following three groups: a control 
group (untreated); a TiO2 group (MNP-free TiO2 microspheres); and an MNP-containing TiO2 
group (RT-30 and RT-60). A cell suspension consisting of 1 × 104 Rat-1 fibroblasts was 
seeded in each well of a 24-well plate with 0.8 mL medium. Using 24-well cell culture inserts, 
which have a porous membrane bottom with a 1.0-µm pore size (Corning, Tewksbury, MA, 
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USA), test samples (TiO2, RT-30, and RT-60) were added to the wells by deposition on the 
membranes of the inserts. The sample groups (TiO2, RT-30, and RT-60) were tested at a 
concentration of 1.2 mg/well. Cell proliferation was examined after 1, 3, and 7 days of culture. 
Total DNA from the cells was extracted using an AllPrep DNA/RNA/Protein Mini Kit 
(Qiagen GmbH, Germany) in accordance with the manufacturer’s protocol.15 Following 
extraction, the DNA concentrations were measured by absorbance at 260 nm using a 
spectrophotometer (GeneQuant Pro, GE Healthcare, UK).16 The values are given as mean 
DNA content, and were derived from five replicates per sample. The results are expressed as 
means ± standard deviations. 
Statistical analysis 
Differences between groups were analyzed using Student’s t-tests. Differences with P values 
of less than 0.05 were considered significant. 
RESULTS AND DISCUSSION 
Figure 1 shows the XRD patterns of samples RT-30 and RT-60 in comparison with that of 
starting MNPs. Sharp diffraction peaks ascribed to magnetite (Fe3O4; PDF: 19-0629) and/or 
maghemite (γ-Fe2O3; PDF: 39-1346) were observed for the present samples and starting 
MNPs, and no diffraction patterns for crystalline TiO2 were observed. In this study, the heat 
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treatment of samples was carried out at 200°C to avoid unwanted oxidation of starting MNPs 
into antiferromagnetic hematite. At the heat treatment temperature of 200°C, the crystallinity 
of TiO2 matrix was still low; therefore, the samples used in this study did not yield obvious 
XRD peaks for crystalline TiO2. These results indicate that the present samples contained 
MNPs and had a low-crystalline TiO2 matrix. 
Figure 2 shows SEM images of samples RT-30 and RT-60. Spherical microspheres of 
approximately 20–30 µm in diameter were successfully obtained. There was no significant 
difference in the morphology of microspheres between samples RT-30 and RT-60, indicating 
that the difference in reaction time barely affected the morphology of the resulting sample. 
Figure 3 shows size distribution curves for samples RT-30 and RT-60. The present samples 
yielded a size distribution in the range from 20 to 40 µm, with one vertex at 30 µm. Notably, 
the size distribution of sample RT-60 was slightly broader than that of RT-30. Although the 
specific mechanism underlying this effect is unclear, the longer reaction time may cause 
growth and deterioration of microspheres simultaneously. In fact, the broader size distribution 
of sample RT-60 could also be observed in lower-magnification SEM images (Fig. 2). 
The sizes of microspheres are critical for intra-arterial hyperthermia. Microspheres should 
have diameters similar to those of capillary vessels (approximately 15–35 µm) in order to 
allow them to embolize the capillary vessels surrounding the tumors. The results shown in 
Figs. 2 and 3 suggested that the samples used in the present study almost met the 
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requirements of embolic agents, and illustrated that the addition of 1-butanol as a cosurfactant 
was effective for increasing the sizes of microspheres from a few micrometers to several 
dozen micrometers. The increase in the sizes of microspheres by addition of a cosurfactant 
can be interpreted as follows. Without cosurfactant, the elasticity and tenacity of the surfactant 
layer around the emulsion droplet may be low. The crystal nucleus can agglomerate to form 
microspheres in the droplet as hydrolysis and polycondensation of TTIP progress, and the 
mass of microspheres increases as the sizes of the microspheres increase. When the sizes of 
microspheres have increased up to several micrometers, the interfacial surfactant layer around 
the emulsion droplet is broken because of the mass of the microspheres, resulting in 
demulsification. As a result, small microspheres are formed without cosurfactant. In contrast, 
with a cosurfactant such as 1-butanol, the fluidity of the interfacial surfactant layer can be 
greatly increased; thus, the interfacial tension of oil-water interfaces can decrease, whereas 
the elasticity and tenacity of the surfactant layer can increase.17 Accordingly, the formed 
interfacial surfactant layer allows microspheres to increase to the upper bounds of the 
diameter and mass of microspheres and therefore, the resulting microspheres are many times 
larger than those prepared without cosurfactant. 
Table 1 shows Ms, Hc, and calculated MNP contents of samples in comparison with those 
of starting MNPs. The Ms was determined by magnetization curves under an applied 
magnetic field of 10 kOe. The Ms values of samples RT-30 and RT-60 were 42.8 and 44.3 
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emu/g, respectively; these values were lower than that of the starting MNPs (73.2 emu/g). 
There are two possible explanations for the lower Ms values of samples compared with that of 
starting MNPs. First, the content of MNPs in samples was lower than that of starting MNPs. 
Second, the coating layer on the MNPs may weaken the superexchange interaction between 
the magnetic moments on iron ions and induce a spin disorder on the surface of MNPs, 
resulting in a lower Ms compared with that of starting MNPs.18,19 
The Hc values of samples RT-30 and RT-60 were 45.0 and 100.0 Oe, respectively. The 
TiO2 shell encapsulating the MNP screens and decreases the magnetic dipole coupling 
interactions between neighboring MNPs, thereby reducing the Hc measured from hysteresis 
loops of samples. On the other hand, Fe3O4 in the starting MNPs may be partially converted 
to γ-Fe2O3 in samples during the sol-gel synthesis procedure. The particle size of γ-Fe2O3 
converted from Fe3O4 is likely to be much larger than that of Fe3O4.
20 For single-domain 
magnetic particles, the Hc increases as the size of the particles increases.21 This factor could 
lead to the observed increase in the Hc values of the samples. For sample RT-60, the Hc was 
almost same as that of the starting MNPs (98.0 Oe) because the two opposite effects described 
above may be well balanced. However, for sample RT-30, Fe3O4 in starting MNPs may be 
only partly converted to γ-Fe2O3 since the sol-gel synthesis procedure reaction time is 
relatively short. As a result, the effects of the TiO2 shell may be dominant, resulting in a 
significant reduction in Hc for sample RT-30. 
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To avoid evaluation errors and to obtain accurate absolute heating measurements, the 
specific absorption rate (SAR) of each sample was analyzed by measuring in vitro 
heat-generation of samples. Figure 4 shows the time-dependent temperature curves of the agar 
phantom under a magnetic field of 100 kHz and 300 Oe. Both of the present samples heated 
the agar phantom to above 43°C after approximately 1 min. From the increase in temperature, 
the value of SAR was calculated using the following equation:20 
 = ∑ 
Δ
Δ
where msample is the mass of sample and Cimi is the heat capacity of each component whose 
temperature is increased in the applied magnetic field (Cagar = 4.2 J/g/K, Cmagnetite = 0.62 J/g/K, 
and Ctitania = 0.69 J/g/K)
22. The term ∆T/∆t is the largest gradient of the time-dependent 
temperature curve. The SAR values calculated for sample RT-30, sample RT-60, and starting 
MNPs are listed in Table 2. Figure 5 shows the magnetization curves of samples measured 
under an applied magnetic field of 300 Oe. The heat generated (P) by samples was calculated 
from the area of these curves and is listed in Table 2. 
We speculates that hysteresis loss mainly contributed to the heat generation of sample 
RT-60 because the SAR value (20 W/g) was lower than the heat generation P (22.3 W/g) 
calculated from the area of the hysteresis loop.10 On the other hand, the SAR value of sample 
RT-30 (19.2 W/g) was higher than the heat generation P (9.1 W/g), suggesting that relaxation 
loss rather than hysteresis loss may contribute to the heat generation of sample RT-30. As 
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described above, the TiO2 shell encapsulating the MNPs may screen and decrease the 
magnetic dipole coupling interactions between neighboring MNPs for sample RT-30, which 
decreases Hc and P calculated from the hysteresis loop. 
Figure 6 shows the DNA concentrations of Rat-1 fibroblasts cultured with different 
samples. No significant differences in DNA concentrations were observed between each 
group after 1 day; however, there were significant differences in DNA concentrations between 
the control group and the TiO2 and sample groups after 3 and 7 days. Because of the low heat 
temperature of 200°C used in this study, it was possible that some chemical reagents remained 
in microspheres and were released into the cell culture medium. Generally, higher 
temperatures are favorable for improving the chemical durability of microspheres; however, 
the heat treatment at high temperatures may oxidize MNPs into antiferromagnetic hematite. 
Additionally, heat treatment at higher temperatures with controlled oxygen partial pressure 
may be effective in improving the in vitro biocompatibility of microspheres. On the other 
hand, we found that there were no significant differences in DNA concentrations between the 
TiO2 and sample groups, suggesting that incorporation of MNPs into TiO2 microspheres did 
not adversely affect the in vitro biocompatibility of microspheres. In addition, Rat-1 
fibroblasts grown in medium with TiO2, sample RT-30, or sample RT-60 did not show 
significant morphological damage after 1, 3, or 7 days of culture (Figure 7). Their 
morphologies remained similar to that of the control group. 
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CONCLUSION 
TiO2 microspheres containing MNPs of approximately 30 µm in diameter were successfully 
obtained by addition of a cosurfactant into a W/O emulsion reaction system. The TiO2 
microspheres containing MNPs (Fe3O4 and/or γ-Fe2O3) of approximately 60 wt% increased 
the temperature of the agar phantom to above 43°C after 1 min and showed in vitro 
biocompatibility similar to that of MNP-free TiO2 microspheres. The TiO2 microspheres 
containing MNPs investigated in the present study are expected to be useful for intra-arterial 
hyperthermia-based treatment of cancer. However, the biocompatibility of these microspheres 
should be further improved by heat treatment at higher temperatures, and additional in vivo 
biocompatibility assessments should be performed. 
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Figure and Table Legends 
FIGURE 1. XRD patterns of samples RT-30 and RT-60, in comparison with those of starting 
MNPs. 
FIGURE 2. SEM images of samples RT-30 and RT-60. 
FIGURE 3. Size distribution curves of samples RT-30 and RT-60. 
FIGURE 4. Time-dependent temperature curves of the agar phantom under a magnetic field 
of 100 kHz and 300 Oe. 
FIGURE 5. Magnetization curves of samples measured under an applied magnetic field of 
300 Oe. 
FIGURE 6. DNA concentrations of Rat-1 fibroblasts cultured with different samples and with 
different concentrations. Data are shown as the mean ± SD (n = 5). *P < 0.05, **P < 0.01. 
FIGURE 7. Representative optical micrographs of Rat-1 fibroblasts grown in medium with 
and without samples after 1, 3, and 7 days of culture. 
TABLE 1. Saturation magnetization (Ms), coercive force (Hc), and calculated MNP contents 
of samples, in comparison with those of staring MNPs. 
TABLE 2. Specific absorption rate (SAR) and heat generation calculated by the hysteresis 
loop (P) of samples. 
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FIGURE 1. XRD patterns of samples RT-30 and RT-60, in comparison with those of starting MNPs. 
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FIGURE 2. SEM images of samples RT-30 and RT-60. 
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FIGURE 3. Size distribution curves of samples RT-30 and RT-60. 
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FIGURE 4. Time-dependent temperature curves of the agar phantom under a magnetic field of 100 kHz and 
300 Oe.  
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FIGURE 5. Magnetization curves of samples measured under an applied magnetic field of 300 Oe. 
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FIGURE 6. DNA concentrations of Rat-1 fibroblasts cultured with different samples and with different 
concentrations. Data are shown as the mean ± SD (n = 5). *P < 0.05, **P < 0.01.  
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FIGURE 7. Representative optical micrographs of Rat-1 fibroblasts grown in medium with and without 
samples after 1, 3, and 7 days of culture.  
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